Latest It Consulting News

Vectus Biosystems is close to finalising a $4.3 million transaction with Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its anti-fibrotic drug candidates amid cost reductions.

PolarX Limited reported steady progress in its Nevada and Alaska exploration projects during the December 2025 quarter, with key drilling programs completed and a significant joint venture funding milestone achieved with Northern Star Resources.

Northern Minerals has made significant strides in developing its Browns Range Heavy Rare Earths Project, securing substantial funding support from US and Australian agencies alongside a $60.5 million capital raise. Exploration success and engineering progress position the company for a Final Investment Decision by late 2026.

Eastern Resources Limited reported a modest cash outflow from operations in the December 2025 quarter but retains a robust cash balance supporting over 18 quarters of funding.

Provaris Energy has made significant strides in hydrogen and liquid carbon dioxide storage technologies, reinforcing key partnerships and securing funding to meet critical 2026 milestones.

Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.

Native Mineral Resources reported steady gold production at its Blackjack operations, completed key plant upgrades, and progressed joint ventures, supported by a $3 million convertible note raise.

Native Mineral Resources reports strong assay results from its Blackjack Gold Project in Queensland, revealing significant shallow gold mineralisation and prompting a restart of mining operations.

Magnetite Mines broadens its strategic partnerships and progresses key approvals for the Razorback Iron Ore Project, while uncovering new rare earth mineralisation and expanding its green iron consortium.

FIN Resources is gearing up to launch its maiden drilling campaign at the high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, with ice road construction starting in early February and drilling expected by March.

Actinogen Medical’s pivotal XanaMIA trial for Alzheimer’s disease has received a green light from its independent Data Monitoring Committee to continue, reinforcing confidence in the drug’s safety and efficacy profile.

Critica Limited has confirmed repeatable high-grade rare earth product quality at its Jupiter Project, delivering an 86% TREO concentrate and demonstrating gallium by-product potential. The company also secured an oversubscribed $8 million placement to fund pilot operations and a scoping study.